2014

Chi-Cheng Lai, Kyungwon Lee, Yonghong Xiao, Norazah Ahmad, Balaji Veeraraghavan, Visanu Thamlikitkul, Paul Ananth Tambyah, R.H.H. Nelwan, Atef M. Shibl, Jiunn-Jong Wu, Wing-Hong Seto and Po-Ren Hsueh (2014). High burden of antimicrobial drug resistance in Asia. Journal of Global Antimicrobial Resistance 2(3): 141-147

The rapid development of antimicrobial resistance among micro-organisms is a serious public health concern. Moreover, the dissemination of antibiotic-resistant bacteria makes this issue a global problem, and Asia is no exception. For example, since New Delhi metallo-b-lactamase (NDM)-producing Enterobacteriaceae were identified in India, further spread of NDM has become a worldwide threat. However, the epidemiology of antibiotic-resistant bacteria in Asia may be different to other regions, and clinical condition may be worse than in western countries. Antibiotic-resistant bacteria, including community-acquired and hospital-acquired meticillin-resistant Staphylococcus aureus (MRSA), vanco-mycin-intermediate S. aureus (VISA), vancomycin-resistant enterococci, macrolide- and penicillin- resistant Streptococcus pneumoniae, extend-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa and Acinetobacter spp., are becoming prevalent in many countries in Asia. Moreover, the prevalence of each antibiotic-resistant bacterium in each country is not identical. This review provides useful information regarding the critical condition of antibiotic resistance in Asia and emphasises the importance of continuous surveillance of resistance data.